Tumour necrosis factor in man: Clinical and biological observationsPeter J. Selby, J HUMPHREYS, Alison Jones et al.|British Journal of Cancer|1987Cited by 203
Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinomaSari F. Alhasan, Helen L. Reeves, Beate Haugk et al.|British Journal of Cancer|2016Cited by 23
The Enhanced In Vivo Activity of the Combination of a MEK and a PI3K Inhibitor Correlates with [18F]-FLT PET in Human Colorectal Cancer Xenograft Tumour-Bearing MiceEmma J. Haagensen, David R. Newell|PLoS ONE|2013Cited by 13